Literature DB >> 9666118

The interrelationship between selective tau phosphorylation and microtubule association.

H Xie1, J M Litersky, J A Hartigan, R S Jope, G V Johnson.   

Abstract

The purpose of this study was to examine the modulation of tau phosphorylation mediated by protein kinase A, a kinase with low intrinsic activity, and by the constitutively active glycogen synthase kinase, as well as to examine the subsequent effects on tau-microtubule association in differentiated human SH-SY5Y neuroblastoma cells. Activation of protein kinase A with forskolin and rolipram significantly increased tau phosphorylation at Ser262/356 only in the presence of okadaic acid, indicating that phosphates at these sites are normally turned over rapidly. In contrast, glycogen synthase kinase appears to maintain tau phosphorylation at Thr181 and Ser396/404 since inhibition of glycogen synthase kinase with lithium reduced phosphorylation at these sites. Lithium treatment also significantly decreased tau and tyrosinated alpha-tubulin levels. Perturbation of microtubules with nocodazole or taxol induced tau dephosphorylation at Tau-1 sites, Thr181 and Ser396/404, indicating that both constitutive kinase activity and microtubule state modulate tau phosphorylation at these sites. Nocodazole- or taxol-induced tau dephosphorylation was blocked by the protein phosphatase 2A/1 inhibitor okadaic acid, but not by the protein phosphatase 2B inhibitor cyclosporin A. In addition, osmotic stress, such as treatment with 20 mM NaCl, selectively increased tau phosphorylation at the Tau-1 epitope. To investigate the effect of phosphorylation on tau association with microtubules and microtubule stability in situ, a Triton X-100 extraction assay was utilized to separate the detergent-soluble cytosolic components from the detergent-insoluble cytoskeletal components. In control cells or cells treated with lithium very little tau was detected in the cytosolic fraction. Activation of protein kinase A in the presence of okadaic acid elevated tau levels in the detergent-soluble fraction, which contained all the tau phosphorylated at Ser262/356, and also decreased microtubule stability, as indicated by decreased acetylated alpha-tubulin levels. In conclusion, the phosphorylation state of tau in differentiated SH-SY5Y cells is regulated by glycogen synthase kinase, microtubule dynamics and osmotic stress at overlapping sites which apparently have little influence on tau-microtubule association. In contrast, phosphorylation of tau at Ser262/356 within the microtubule-binding, which was mediated in part by protein kinase A, prevented the association of tau with microtubules in situ. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666118     DOI: 10.1016/s0006-8993(98)00407-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Phosphorylated tau can promote tubulin assembly.

Authors:  H C Tseng; Q Lu; E Henderson; D J Graves
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Kim N Green; Kevin Liang; Levina Tran; Yiling Chen; Frances M Leslie; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-10       Impact factor: 11.205

3.  Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases.

Authors:  Yang Yu; Xiaoqin Run; Zhihou Liang; Yi Li; Fei Liu; Ying Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

4.  Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis.

Authors:  Mien V Hoang; Janice A Nagy; Joan E B Fox; Donald R Senger
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

Review 5.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

6.  Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.

Authors:  Emmanuel Planel; Pavan Krishnamurthy; Tomohiro Miyasaka; Li Liu; Mathieu Herman; Asok Kumar; Alexis Bretteville; Helen Y Figueroa; Wai Haung Yu; Robert A Whittington; Peter Davies; Akihiko Takashima; Ralph A Nixon; Karen E Duff
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

7.  Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn.

Authors:  Timothy Me Scales; Pascal Derkinderen; Kit-Yi Leung; Helen L Byers; Malcolm A Ward; Caroline Price; Ian N Bird; Timothy Perera; Stuart Kellie; Ritchie Williamson; Brian H Anderton; C Hugh Reynolds
Journal:  Mol Neurodegener       Date:  2011-01-26       Impact factor: 14.195

8.  Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms.

Authors:  Maxime Derisbourg; Coline Leghay; Giovanni Chiappetta; Francisco-Jose Fernandez-Gomez; Cyril Laurent; Dominique Demeyer; Sébastien Carrier; Valérie Buée-Scherrer; David Blum; Joëlle Vinh; Nicolas Sergeant; Yann Verdier; Luc Buée; Malika Hamdane
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

Review 9.  Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.

Authors:  Touqeer Ahmed; Saadia Zahid; Aamra Mahboob; Syeda Mehpara Farhat
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

10.  Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.

Authors:  Rik van der Kant; Vanessa F Langness; Cheryl M Herrera; Daniel A Williams; Lauren K Fong; Yves Leestemaker; Evelyne Steenvoorden; Kevin D Rynearson; Jos F Brouwers; J Bernd Helms; Huib Ovaa; Martin Giera; Steven L Wagner; Anne G Bang; Lawrence S B Goldstein
Journal:  Cell Stem Cell       Date:  2019-01-24       Impact factor: 24.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.